Rescue hCG to treat empty follicle syndrome after the use of a GnRH agonist as oocyte maturation trigger: First report on fresh embryo transfer and clinical pregnancy

References

• Abramov, Y., Barak, V., Nisman, B., & Schenker, J.G. (1997). Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertility and Sterility, 67, 261–265.
   PubMed Web of Science ®Google Scholar
• Albert, C., Garrido, N., Mercader, A., Rao, C.V., Remohí, J., Simón, C., & Pellicer, A. (2002). The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome. Molecular Human Reproduction, 8, 409–418.
   PubMed Web of Science ®Google Scholar
• Asada, Y., Itoi, F., Honnma, H., Takiguchi, S., Fukunaga, N., Hashiba, Y., et al. (2013). Failure of GnRH agonist-triggered oocyte maturation: its cause and management. Journal of Assisted Reproduction and Genetics, 30, 581–585.
   PubMed Web of Science ®Google Scholar
• Castillo, J.C., Garcia-Velasco, J., & Humaidan, P. (2012). Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS. Journal of Assisted Reproduction and Genetics, 29, 249–253.
   PubMed Web of Science ®Google Scholar
• Cerrillo, M., Pacheco, A., Rodríguez, S., Gómez, R., Delgado, F., Pellicer, A., & Garcia-Velasco, J.A. (2011). Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome. Fertility and Sterility, 95, 2517–2519.
   PubMed Web of Science ®Google Scholar
• Chen, S.L., Ye, D.S., Chen, X., Yang, X.H., Zheng, H.Y., Tang, Y., et al. (2012). Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol. Human Reproduction, 27, 1351–1356.
   PubMed Web of Science ®Google Scholar
• Damewood, M.D., Shen, W., Zacur, H.A., Schlaff, W.D., Rock, J.A., & Wallach, E.E. (1989). Disappearance of exogenously administered human chorionic gonadotropin. Fertility and Sterility, 52, 398–400.
   PubMed Web of Science ®Google Scholar
• Delvigne, A. & Rozenberg, S. (2002). Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Human Reproduction Update, 8, 559–577.
   PubMed Web of Science ®Google Scholar
• Engmann, L., DiLuigi, A., Schmidt, D., Nulsen, J., Maier, D., & Benadiva, C. (2008). The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertility and Sterility, 89, 84–91.
   PubMed Web of Science ®Google Scholar
• Fauser, B.C., de Jong, D., Olivennes, F., Wramsby, H., Tay, C., Itskovitz-Eldor, J., & van Hooren, H.G. (2002). Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. Journal of Clinical Endocrinology and Metabolism, 87, 709–715.
   PubMed Web of Science ®Google Scholar
• Griesinger, G., von Otte, S., Schroer, A., Ludwig, A.K., Diedrich, K., Al-Hasani, S., & Schultze-Mosgau, A. (2007). Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Human Reproduction, 22, 1348–1352.
   PubMed Web of Science ®Google Scholar
• Griesinger, G., Schultz, L., Bauer, T., Broessner, A., Frambach, T., & Kissler, S. (2011). Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a “freeze-all” strategy: a prospective multicentric study. Fertility and Sterility, 95, 2029–2033.
   PubMed Web of Science ®Google Scholar
• Hoff, J.D., Quigley, M.E., & Yen, S.S. (1983). Hormonal dynamics at midcycle: a reevaluation. Journal of Clinical Endocrinology and Metabolism, 57, 792–796.
   PubMed Web of Science ®Google Scholar
• Honnma, H., Hashiba, Y., Asada, Y., & Endo, T. (2011). Failure of triggering oocyte maturation with a GnRH agonist in polycystic ovary syndrome: two case reports. European Journal of Obstetrics Gynecology and Reproductive Biology, 157, 239–240.
   PubMed Web of Science ®Google Scholar
• Humaidan, P., Kol, S., & Papanikolaou, E.G., Copenhagen GnRH Agonist Triggering Workshop Group. (2011). GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Human Reproduction Update, 17, 510–524.
   PubMed Web of Science ®Google Scholar
• Itskovitz, J., Boldes, R., Levron, J., Erlik, Y., Kahana, L., & Brandes, J.M. (1991). Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertility and Sterility, 56, 213–220.
   PubMed Web of Science ®Google Scholar
• Itskovitz-Eldor, J., Kol, S., & Mannaerts, B. (2000). Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication. Human Reproduction, 15, 1965–1968.
   PubMed Web of Science ®Google Scholar
• Kol, S. (2004). Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertility and Sterility, 81, 1–5.
   PubMed Web of Science ®Google Scholar
• Kolibianakis, E.M., Collins, J., Tarlatzis, B.C., Devroey, P., Diedrich, K., & Griesinger, G. (2006). Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Human Reproduction Update, 12, 651–671.
   PubMed Web of Science ®Google Scholar
• Kummer, N.E., Feinn, R.S., Griffin, D.W., Nulsen, J.C., Benadiva, C.A., & Engmann, L.L. (2013). Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger. Human Reproduction, 28, 152–159.
   PubMed Web of Science ®Google Scholar
• Pellicer, A., Albert, C., Mercader, A., Bonilla-Musoles, F., Remohí, J., & Simón, C. (1999). The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor. Fertility and Sterility, 71, 482–489.
   PubMed Web of Science ®Google Scholar
• Stevenson, T.L. & Lashen, H. (2008). Empty follicle syndrome: the reality of a controversial syndrome, a systematic review. Fertility and Sterility, 90, 691–698.
   PubMed Web of Science ®Google Scholar
• Tang, H., Hunter, T., Hu, Y., Zhai, S.D., Sheng, X., & Hart, R.J. (2012). Cabergoline for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews, 2, CD008605. DOI: 10.1002/14651858.CD008605.pub2.
   Google Scholar
• Tomazevic, T. & Meden-Vrtovec, H. (1996). Early timed follicular aspiration prevents severe ovarian hyperstimulation syndrome. Journal of Assisted Reproduction and Genetics, 13, 282–286.
   PubMed Web of Science ®Google Scholar